Literature DB >> 10901738

New treatments for smoking cessation.

J R Hughes1.   

Abstract

Helping cigarette smokers to permanently stop smoking is one of the most effective ways to prevent cancer. A physician's instruction to a patient to stop smoking and to offer assistance in this endeavor is an important motivator. Current guidelines state that clinicians should encourage all smokers who want to quit to use medications and should offer psychosocial therapies, as well. It has been shown that even brief clinician advice about smoking cessation increases quit rates. Five medications--bupropion, nicotine gum, nicotine inhaler, nicotine nasal spray, and nicotine patch--and one proven psychosocial therapy (behavior therapy) appear equally effective and safe; i.e., they all double quit rates and are associated with a less than 5% dropout rate due to adverse events. In 1998, approximately one third of those who attempted to quit smoking used a medication. Attending group behavior therapy to supplement medications increases quit rates but is not essential for medications to work. As there are no proven treatment-matching protocols, patients should choose the treatment(s) they believe will be most effective for them. In the future, people who continue to smoke will be individuals with severe nicotine dependence or psychiatric symptoms; thus, clinicians will increasingly be called on to provide pharmacotherapy for smoking cessation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901738     DOI: 10.3322/canjclin.50.3.143

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  5 in total

1.  Improving the treatment of tobacco dependence.

Authors:  M Thun; T J Glynn
Journal:  BMJ       Date:  2000-08-05

2.  Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.

Authors:  Vincenzo Teneggi; Stephen T Tiffany; Lisa Squassante; Stefano Milleri; Luigi Ziviani; Alan Bye
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

3.  [Varenicline - pharmacological therapy of tobacco dependence].

Authors:  Patricia Tschabitscher; Irmgard Homaier; Alfred Lichtenschopf; Ernest Groman
Journal:  Wien Med Wochenschr       Date:  2009

Review 4.  A systematic review of possible serious adverse health effects of nicotine replacement therapy.

Authors:  Peter N Lee; Marc W Fariss
Journal:  Arch Toxicol       Date:  2016-10-03       Impact factor: 5.153

5.  Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers.

Authors:  Michael Chaiton; Lori Diemert; Joanna E Cohen; Susan J Bondy; Peter Selby; Anne Philipneri; Robert Schwartz
Journal:  BMJ Open       Date:  2016-06-09       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.